Outpatient Management of Fever and Neutropenia in Low-risk Children with Solid Tumors: A Quality Improvement Initiative

被引:1
|
作者
Bourgeois, Wallace [1 ,2 ]
Paolino, Jonathan [1 ,2 ]
Garland, Riley [1 ,2 ]
Campbell, Kevin [1 ,2 ]
Alvarez-Calderon, Francesca [1 ,2 ]
Frazier, A. Lindsay [1 ,2 ]
O'Neill, Allison F. [1 ,2 ]
Ilowite, Maya [1 ,2 ]
Wong, Chris I. [1 ,2 ,3 ,4 ]
机构
[1] Dana Farber Canc Inst, Boston Childrens Canc & Blood Disorders Ctr, Boston, MA USA
[2] Harvard Med Sch, Dept Pediat Oncol, Boston, MA USA
[3] Univ Hosp Rainbow Babies & Childrens Hosp, Div Pediat Hematol & Oncol, 11100 Euclid Ave, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Univ Hosp Seidman Canc Ctr, Div Hematol Oncol, Sch Med, Cleveland, OH USA
关键词
CANCER;
D O I
10.1097/pq9.0000000000000771
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background:Management of febrile neutropenia in pediatric oncology usually requires inpatient parenteral antibiotics after initial evaluation, but some patients at lower risk of sepsis could be safely managed outpatient. We describe a quality improvement project to increase outpatient management of fever and neutropenia.Methods:We designed a standardized algorithm for children with a solid tumor diagnosis and low risk for bacteremia. The aim was to achieve outpatient management for at least 80% of eligible patients within 20 months of project initiation. We used plan-do-study-act cycles to improve algorithm compliance, including optimizing medical record decision support, developing targeted educational materials and outreach, and restructuring outpatient processes to allow for close follow-up. We surveyed patients (age >= 12 y) and parents/caregivers to assess the impact of outpatient management.Results:The initiative led to 71% (n = 34) of eligible patients being managed as outpatients. Six percent (n = 2) of patients developed bacteremia, resulting in hospital admission. Fifteen of 26 parents/caregivers and five of 11 patients approached completed the survey. For the preferred setting of febrile neutropenia management, 83% of patients preferred to be home versus 40% of parents/caregivers. No patient expressed any of the three highest ratings in the question exploring fear regarding outpatient febrile neutropenia management versus 67% of parents/caregivers.Conclusions:Some children with a solid tumor diagnosis at low risk for bacteremia are safely managed for febrile neutropenia as outpatients. Targeted efforts to engage parents/caregivers early in this practice change are necessary for success.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Inpatient versus outpatient management of low-risk pediatric febrile neutropenia: Measuring parents' and healthcare professionals' preferences
    Sung, L
    Feldman, BM
    Schwamborn, G
    Paczesny, D
    Cochrane, A
    Greenberg, ML
    Maloney, AM
    Hendershot, EL
    Naqvi, A
    Barrera, M
    Llewellyn-Thomas, HA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (19) : 3922 - 3929
  • [32] Potential reduction of hospital stay length with outpatient management of low-risk febrile neutropenia in a regional cancer center
    Nguyen, Mike
    Jacobson, Tate
    Torres, Javier
    Wann, Alysson
    CANCER REPORTS, 2021, 4 (03)
  • [33] Low-risk prediction rule for pediatric oncology patients presenting with fever and neutropenia
    Klaassen, RJ
    Goodman, TR
    Pham, B
    Doyle, JJ
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (05) : 1012 - 1019
  • [34] Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection
    Santolaya, ME
    Alvarez, AM
    Avilés, CL
    Becker, A
    Cofré, J
    Cumsille, MA
    O'Ryan, ML
    Payá, E
    Salgado, C
    Silva, P
    Tordecilla, J
    Varas, M
    Villarroel, M
    Viviani, T
    Zubieta, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (18) : 3784 - 3789
  • [35] Safety and effectiveness of outpatient therapy in 596 low-risk patients with febrile neutropenia (FN)
    Elting, L
    Lu, C
    Escalante, C
    Giordano, S
    Trent, J
    Avritscher, E
    Gralla, R
    Talcott, J
    Rolston, K
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 758S - 758S
  • [36] Economic outcomes of outpatient treatment of low-risk febrile neutropenia during cancer chemotherapy
    McNabb, J
    Freifeld, AG
    Yee, GC
    Brannan, R
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1227 - 1227
  • [37] Shorter Duration of Antibiotics in Low-Risk Febrile Neutropenia in Children with Malignancy
    Jagdish Prasad Meena
    Aditya Kumar Gupta
    The Indian Journal of Pediatrics, 2021, 88 : 217 - 218
  • [38] Shorter Duration of Antibiotics in Low-Risk Febrile Neutropenia in Children with Malignancy
    Meena, Jagdish Prasad
    Gupta, Aditya Kumar
    INDIAN JOURNAL OF PEDIATRICS, 2021, 88 (03): : 217 - 218
  • [39] Early discharge of pediatric patients with cancer, fever, and neutropenia with low-risk of systemic infection
    Gil-Veloz, Mariana
    Pacheco-Rosas, Daniel O.
    Solorzano-Santos, Fortino
    Villasis-Keeyer, Miguel A.
    Betanzos-Cabrera, Yadira
    Miranda-Novales, Guadalupe
    BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO, 2018, 75 (06): : 352 - 357
  • [40] MANAGEMENT OF LOW-RISK METASTATIC GESTATIONAL TROPHOBLASTIC TUMORS
    DUBESHTER, B
    BERKOWITZ, RS
    GOLDSTEIN, DP
    BERNSTEIN, MR
    JOURNAL OF REPRODUCTIVE MEDICINE, 1991, 36 (01) : 36 - 39